Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × fludarabine × Plasma cell × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 82 INDUSTRY 23 NIH 6 OTHER_GOV 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 9 Lymphoid 8 Myeloid 4 Other neoplasm 2 Sarcoma 1 Plasma cell 1 Genitourinary 1 Classical hematology 1 Breast 1

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 40 Bortezomib 20 Lenalidomide 18 Cyclophosphamide 17 daratumumab 15 Melphalan 12 Calcium Dobesilate 12 Thalidomide 11 Prednisone 7 carfilzomib 6 Peripheral Blood Stem Cell Transplantation 6 pomalidomide 5 dexamethasone acetate 5 dexamethasone 21-phosphate 5 auricularum 5 Doxorubicin 5 Filgrastim 4 isatuximab 3 Vincristine 3 Interferon-alpha 3 selinexor 2 sargramostim 2 ixazomib 2 elotuzumab 2 cobimetinib 2 belantamab mafodotin 2 Steroids 2 Radiotherapy 2 Microarray Analysis 2 Gene Expression Profiling 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05257083 2026-03-17

CARTITUDE-6

European Myeloma Network B.V.

Phase 3 Active not recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡